Michelson Diagnostics
11A Grays Farm Production Village
Grays Farm Road
Orpington
Kent
BR5 3BD
United Kingdom
Tel: 44-208-3081695
Fax: 44-121-2756237
Website: http://www.md-ltd.co.uk/
21 articles about Michelson Diagnostics
-
Michelson Diagnostics: Imaging Reveals Changes in Blood Vessel Growth in Deadly Melanoma Skin Cancer
12/3/2018
A new clinical study has shown that Dynamic Optical Coherence Tomography imaging of melanomas (D-OCT) reveals changes to the blood vessels that correlate with the depth of invasion of the melanoma.
-
Sciton Announces Collaboration With Michelson Diagnostics to Develop OCT Image-Guided Laser Applications
11/1/2017
"VivoSight OCT integrates well into our product portfolio," remarks Dan Negus, President of Sciton.
-
Michelson Diagnostics: Use Of Vivosight OCT Scanner Significantly Improves Early-Stage Diagnosis Of Basal Cell Carcinoma And Reduces Need For Skin Biopsies
10/20/2015
-
Michelson Diagnostics Release: Presentation At The World Congress Of Dermatology
6/15/2015
-
Michelson Diagnostics Release: Transformative Clinical Results With Vivosight In The Diagnosis Of Basal Cell Carcinoma: Data To Be Presented At The World Congress Of Dermatology In Vancouver
6/12/2015
-
Michelson Diagnostics Release: Landmark VivoSight OCT Clinical Study Published In British Journal Of Dermatology
4/30/2015
-
Michelson Diagnostics Launches Next Generation OCT System - Vivosight Dx
4/30/2015
-
Michelson Diagnostics Release: Landmark Vivosight OCT Clinical Study Published In British Journal Of Dermatology
4/29/2015
-
Michelson Diagnostics Appoints Peter Senger As Country Manager Germany
4/13/2015
-
Michelson Diagnostics Closes £ 2.5 Million First Tranche Of £ 4.0 Million Series B Fundraising
2/16/2015
-
Michelson Diagnostics Release: Andy Hill Appointed Chief Executive Officer
2/2/2015
-
Michelson Diagnostics To Present At Fortbildungswoche, Munich
7/18/2014
-
Michelson Diagnostics Release: New Study On Non-Invasive Diagnosis Of Non-Melanoma Skin Cancer With Melanoma Institute Of Australia
5/19/2014
-
Positive Results From Multi-Centre, Prospective Clinical Trial For Diagnosis Of Basal Cell Carcinoma Using Michelson Diagnostics' Vivosight OCT Presented At American Academy of Dermatology
3/21/2014
-
Michelson Diagnostics Vivosight OCT Scanner
2/14/2014
-
Michelson Diagnostics Release: Revolutionary Device for Use in Detecting Non-Melanoma Skin Cancer in Real Time, Alleviates Patient Stress, Can Reduce Invasive Biopsy
9/12/2011
-
Michelson Diagnostics Announces US Expansion
7/14/2011
-
Michelson Diagnostics VivoSight(TM) OCT Scanner Receives FDA 510(k) Clearance
1/13/2010
-
Michelson Diagnostics Receives New Funding to Accelerate Growth
1/5/2010
-
Michelson Diagnostics Awarded CE-Mark for Clinical Use of Its VivoSight OCT Scanner in Europe and for Non-Clinical Applications Worldwide
9/18/2009